Article

Tumor-Infiltrating Lymphocytes Display Prognostic Signatures Associated with Chemotherapy Response in TNBC Patients

2024-11-04

Abstract excerpt

Triple-negative breast cancer (TNBC) is an aggressive subtype often marked by resistance to neoadjuvant chemotherapy (NAC), making treatment particularly challenging. Tumor-infiltrating lymphocytes (TILs), crucial players in the immune landscape of tumors, have been associated with treatment outcomes, but the prognostic potential of TIL-derived gene markers in pre-NAC samples from TNBC patients remains understudie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cde0308e-2afe-5c0f-a550-05de0cf05977
DOI: 10.1101/2024.11.01.621478

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor-Infiltrating Lymphocytes Display Prognostic Signatures Associated with Chemotherapy Response in TNBC PatientsDOI 10.1101/2024.11.01.621478Read

A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerSemantic proximity Read

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast CancerSemantic proximity Read

Immune checkpoints expression patterns predict prognosis and immune microenvironment remodeling in triple-negative breast cancerSemantic proximity Read

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity Read

The expression profiles of signature genes from CD103+LAG3+ tumour-infiltrating lymphocyte subsets predict breast cancer survivalSemantic proximity Read

Decoding gene regulatory circuitry underlying TNBC chemoresistance reveals biomarkers for therapy response and therapeutic targetsSemantic proximity Read

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Semantic proximity Read

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancerSemantic proximity Read

Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype ShiftsSemantic proximity Read

Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancerSemantic proximity Read

Integrated single-cell and bulk RNA sequencing analysis identifies the predictive signature for prognosis and neoadjuvant chemotherapy responses in breast cancerSemantic proximity Read